IVW

ISHARES TR

IVW·464287309·US·ETF·Unknown - Unknown

IVW (ISHARES TR) is held by 161 institutional investors as of Q1 2026. Largest holders: ENVESTNET ASSET MANAGEMENT INC ($5.6B), JPMORGAN CHASE & CO ($4.4B), MORGAN STANLEY ($3.9B). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 86 funds bought IVW.

161
Holders
(22 Elite)
$34.6B
Total Value
53% (162)
Consensus
86 buying - 76 selling
13F: Insider & Congress:
IVWSmart Money Verdict
View all
Held by 161 funds
22 elite
Who's Trading
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000Jan 29, 2026
CongressJohn BoozmanJohn BoozmanBuy $1,001 - $15,000Dec 31, 2025
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000Apr 8, 2025
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000Mar 19, 2025
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000Feb 26, 2025
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000Feb 14, 2025
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000Jan 28, 2025
CongressJohn BoozmanJohn BoozmanSale $1,001 - $15,000May 31, 2024
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
49.3M(+13.0%)$5.6B1.5%+66.76%
57
Decreased
40.5M(-0.6%)$4.4B0.3%+35.93%
0
Increased
34.3M(+2.0%)$3.9B0.2%+48.88%
39
Increased
20.9M(+5.4%)$2.4B0.6%+65.36%
47
Increased
19.8M(+6.6%)$2.2B0.2%+34.56%
41
Increased
15.4M(+2.2%)$1.7B0.3%+92.99%
39
Decreased
8.6M(-1.3%)$970.3M0.1%+141.72%
0
Decreased
8M(-5.8%)$906M0.2%+104.90%
0
Increased
7.3M(+5.3%)$824.7M0.8%+115.92%
47
Decreased
5.4M(-0.7%)$609.7M0.4%+113.93%
0
Increased
4.8M(+5.4%)$537.8M0.6%+48.23%
47
Increased
4.5M(+2.5%)$512.6M0.0%+35.67%
32
Increased
4.3M(+0.3%)$484.8M0.1%+36.41%
31
Increased
3.9M(+868x)$442.8M1.5%+16.86%
79
Decreased
3.9M(-10.7%)$440.1M0.1%+35.33%
0
Increased
3.9M(+2.3%)$438.2M1.3%+62.86%
50
Decreased
3.7M(-1.2%)$413.3M2.3%+66.05%
0
Decreased
3.6M(-2.7%)$403.3M0.5%+103.21%
0
Increased
3.5M(+5.8%)$400.6M0.1%+33.38%
33
Decreased
3.3M(-8.5%)$377.3M1.0%+61.59%
0

Showing 1-20 of 173

1 / 9

Other Unknown stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used